PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

623 analyses · 59 new this week · updated Nov 20
Welcome to PharmD Signal™
Peer-reviewed clinical pharmacy literature, analyzed for practicing pharmacists. Set your topics to personalize.
Free daily alerts
New clinical pharmacy evidence, graded, in your inbox

A pharmacist's take and a GRADE rating on each new study, plus 1 full deep analysis free every month. No credit card.

Already a member? Log in · Want everything? See Premium

⭐ Featured Analysis
★ Editor's Pick Endocrinology / Diabetes / Obesity Practice-changing Grade: Moderate

Retatrutide Delivers 18.8% Weight Loss in Type 2 Diabetes at 80 Weeks

In TRIUMPH-2, retatrutide 12 mg cut body weight 18.8% over 80 weeks in adults with type 2 diabetes, versus 5.1% on placebo.

Read Full Analysis →
Newest Analyses
★ Editor's Picks
Most-read this week